Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation Journal Article


Authors: van Roessel, I.; Prockop, S.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; O'Reilly, R. J.; Kernan, N. A.; Cancio, M.; Boelens, J. J.
Article Title: Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
Abstract: Background: An association between early CD4+ T cell immune reconstitution (CD4+ IR) and survival after T-replete allogeneic hematopoietic cell transplantation (HCT) has been previously reported. Here we report validation of this relationship in a separate cohort that included recipients of ex vivo T-cell-depleted (TCD) HCT. We studied the relationship between CD4+ IR and clinical outcomes. Methods: A retrospective analysis of children/young adults receiving their first allogeneic HCT for any indication between January 2008 and December 2017 was performed. We related early CD4+ IR (defined as achieving >50 CD4+ T cells/μL on two consecutive measures within 100 days of HCT) to overall survival (OS), relapse, non-relapse mortality (NRM), event-free survival (EFS) and acute graft-versus-host disease (aGVHD). Fine and Gray competing risk models and Cox proportional hazard models were used. Results: In this analysis, 315 patients with a median age of 10.4 years (interquartile range 5.0–16.5 years) were included. The cumulative incidence of CD4+ IR at 100 days was 66.7% in the entire cohort, 54.7% in TCD (N = 208, hazard ratio [HR] 0.47, P < 0.001), 90.0% in uCB (N = 40) and 89.6% in T-replete (N = 47) HCT recipients. In multi-variate analyses, not achieving early CD4+ IR was a predictor of inferior OS (HR 2.35, 95% confidence interval [CI] 1.46–3.79, P < 0.001) and EFS (HR 1.80, 95% CI 1.20–2.69, P = 0.004) and increased NRM (HR 6.58, 95% CI 2.82–15.38, P < 0.001). No impact of CD4+ IR on relapse or aGVHD was found. Within the TCD group, similar associations were observed. Conclusion: In this HCT cohort, including recipients of TCD HCT, we confirmed that early CD4+ IR was an excellent predictor of outcomes. Finding strategies to predict or improve CD4+ IR may influence outcomes. © 2020 International Society for Cell and Gene Therapy
Keywords: pediatric; immune reconstitution; t-cell reconstitution; cd4 t cells; hematopoietic transplant
Journal Title: Cytotherapy
Volume: 22
Issue: 9
ISSN: 1465-3249
Publisher: Elsevier Science Ltd.  
Date Published: 2020-09-01
Start Page: 503
End Page: 510
Language: English
DOI: 10.1016/j.jcyt.2020.05.005
PUBMED: 32622752
PROVIDER: scopus
PMCID: PMC7484404
DOI/URL:
Notes: Article -- Export Date: 1 September 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kernan
    512 Kernan
  2. Farid Boulad
    329 Boulad
  3. Susan E Prockop
    262 Prockop
  4. Kevin Joseph Curran
    149 Curran
  5. Richard O'Reilly
    748 O'Reilly
  6. Barbara Spitzer
    78 Spitzer
  7. Elizabeth Klein
    50 Klein
  8. Maria   Cancio
    58 Cancio
  9. Andrew L Kung
    97 Kung
  10. Jaap Jan Boelens
    213 Boelens